The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy.

نویسندگان

  • Florian Heinen
  • Kaat Desloovere
  • A Sebastian Schroeder
  • Steffen Berweck
  • Ingo Borggraefe
  • Anya van Campenhout
  • Guro L Andersen
  • Resa Aydin
  • Jules G Becher
  • Günther Bernert
  • Ignacio Martinez Caballero
  • Lucinda Carr
  • Emmanuelle Chaleat Valayer
  • Maria Teresa Desiato
  • Charlie Fairhurst
  • Paul Filipetti
  • Ralph-Ingo Hassink
  • Ulf Hustedt
  • Marek Jozwiak
  • Serdar Ibrahim Kocer
  • Elisabeth Kolanowski
  • Ingeborg Krägeloh-Mann
  • Sehim Kutlay
  • Helena Mäenpää
  • Volker Mall
  • Paul McArthur
  • Edith Morel
  • Antigone Papavassiliou
  • Ignacio Pascual-Pascual
  • Søren Anker Pedersen
  • Frank S Plasschaert
  • Irene van der Ploeg
  • Olivier Remy-Neris
  • Anne Renders
  • Guiseppe Di Rosa
  • Maja Steinlin
  • Kristina Tedroff
  • Joan Vidal Valls
  • Elke Viehweger
  • Guy Molenaers
چکیده

An interdisciplinary European group of clinical experts in the field of movement disorders and experienced Botulinum toxin users has updated the consensus for the use of Botulinum toxin in the treatment of children with cerebral palsy (CP). A problem-orientated approach was used focussing on both published and practice-based evidence. In part I of the consensus the authors have tabulated the supporting evidence to produce a concise but comprehensive information base, pooling data and experience from 36 institutions in 9 European countries which involves more than 10,000 patients and over 45,000 treatment sessions during a period of more than 280 treatment years. In part II of the consensus the Gross Motor Function Measure (GMFM) and Gross Motor Function Classification System (GMFCS) based Motor Development Curves have been expanded to provide a graphical framework on how to treat the motor disorders in children with CP. This graph is named "CP(Graph) Treatment Modalities - Gross Motor Function" and is intended to facilitate communication between parents, therapists and medical doctors concerning (1) achievable motor function, (2) realistic goal-setting and (3) treatment perspectives for children with CP. The updated European consensus 2009 summarises the current understanding regarding an integrated, multidisciplinary treatment approach using Botulinum toxin for the treatment of children with CP.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Effect of Foot Serial Casting Along with Botulinum Toxin Type-A Injection on Spasticity in Children with Cerebral Palsy

Background & Aims: The goal of this study was to determine the effect of foot serial casting along with botulinum toxin type-A injection on spasticity in children with cerebral palsy. Methods: This study was a randomized clinical trial performed as a pre-post, double blind study. It was performed on 25 children with hemiplegia and diplegia (2-8 years) in Tehran city, who were referred to valias...

متن کامل

Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement.

Botulinum neurotoxin type-A (BoNT-A) has been used in association with other interventions in the management of spasticity in children with cerebral palsy (CP) for almost two decades. This consensus statement is based on an extensive review of the literature by an invited international committee. The use of BoNT-A in the lower limbs of children with spasticity caused by CP is reported using the...

متن کامل

Use of botulinum toxin A in management of children with cerebral palsy.

QUESTION What is the role of intramuscular botulinum toxin injections in the management of spasticity and related morbidity in children with cerebral palsy? ANSWER When botulinum toxin A is injected into the limbs of children with spastic paresis, it induces temporary reduction in muscle tone. It also promotes better motor function when used in combination with conservative treatments such as...

متن کامل

The use of Botulinum toxin in Management of Spasticity and a review of injection techniques in relation to children with cerebral palsy

The use of Botulinum toxin type A (BTX-A) to manage focal spasticity in children with cerebral palsy has been rapid evolving since 1990. The success of BTX-A injections is very dependent on delivery of the toxin into the targeted muscle. The method of delivery however is not agreed upon and differs between patient populations. This paper reviews the different techniques for muscle localisation ...

متن کامل

Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review.

Management of children with cerebral palsy (CP) is the focus of considerable resources in many countries, so that evaluation of the efficacy for new and established treatments is imperative. Botulinum toxin type A (BTX-A) is a relatively new method of spasticity management in children with cerebral palsy. It has been the focus of extensive research since its application to cerebral palsy 10 yea...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

دوره 14 1  شماره 

صفحات  -

تاریخ انتشار 2010